G20 snubs COVID patent waiver, waters down pledge on WHO’s funding
Related Articles
Even after US shift, opponents resist COVID-19 vaccine patent waiver
A deal on an intellectual property waiver for COVID-19 vaccines at the World Trade Organization (WTO) was no closer to acceptance on Monday (31 May) despite Washington’s backing.
Italy, G20 look to return of tourism
Italy is ready to welcome back travellers, Prime Minister Mario Draghi said Tuesday (4 May) after hosting a G20 meeting that put tourism at the heart of the global post-pandemic recovery.
G7 pledge cooperation on carbon leakage as EU border tariff looms
The Group of Seven leaders on Sunday (13 June) pledged to work together to tackle carbon leakage, weeks before the European Union is due to propose a world-first plan to impose CO2 emission costs on imports of certain polluting goods.
France’s chief of staff steps down from role
France’s top military official, General François Lecointre, has announced that he will step down on 21 July. The current army chief of staff, General Thierry Burkhard, will take over, the Elysée Palace said. He will be responsible for implementing the…
US-Germany rift could scupper vaccine patent waiver
A bold US bid to waive patents on much-needed coronavirus vaccines was strongly opposed by Germany on Thursday (6 May), threatening to derail the proposal that requires the consensus of World Trade Organisation members to pass.
Responses